Therapeutic Agent for Pruritus Comprising P38 Map Kinase Inhibitor as the Active Ingredient
申请人:Kato Masatomo
公开号:US20080119498A1
公开(公告)日:2008-05-22
An object of the present invention is to find a novel pharmacological effect (a medicinal use) of a p38 MAP kinase inhibitor. Because of having an excellent antipruritic effect, a p38 MAP kinase inhibitor is useful as a therapeutic agent for pruritus of any types such as ocular pruritus, skin pruritus and systemic pruritus.